WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

IMPACT OF COVID-19 IN ALZHEIMER’S PATIENT’S

Swathy N. S.*, Mobin P. Chacko, Prasobh G. R. and Grace N. Raju

Abstract

Due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV- 2) causes Alzhemer’s disease a neurological complication of COVID- 19. In AD patients multiple pathological changes such as the excessive expression of viral receptor angiotensin converting enzyme 2 and proinflammatory molecules may increase morbidity and mortality of covid 19. various neurologic symptoms like cognitive impairment has reported in covid 19 that may results in AD, SARS-CoV-2 may invade into the central nervous system, COVID-19- may induce inflammation, long-term hospitalization and delirium, and post-COVID-19 syndrome. In addition, uninfected AD patients behavioral symptoms may be worsen by covid 19 crisis and provide new challenges for AD prevention. In this review.we first know about the SARS-CoV-2 and AD-COVID-19.

Keywords: COVID-19, SARS-CoV-2, Alzheimer’s disease, Inflammation, Central nervous system.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More